Papers to Appear in Forthcoming Issues

(Received and Accepted Dates Follow Title) tion of CS1 Fibronectin Expression and Function by IL-1 in Endothelial Cells. David L. Boyle, Yan Shi, Steffen Gay, and Gary S. Firestein. (Received 7/23/99; accepted 1/5/00.) toimmune Accelerating Yaa Mutation Does Not Accelerate Murine AIDS. Ambros W. Hügin, Liliane Fossati-Jimack, and Shozo Izui. (Received 8/18/99; accepted 1/5/00.) Ligands on Human Dendritic Cells and Identification of a Peanut Agglutinin Positive Subset in Blood. H. Sherbini, B. Hock, D. Fearnley, A. McLellan, S. Vuckovic, and D. N. J. Hart. (Received 9/9/99; accepted 1/5/00.) s and Antibodies in the Pathogenesis of Myelin Injury in Semliki Forest Virus Encephalomyelitis. Tamar A. Smith-Norowitz, Raymond A. Sobel, and Foroozan Mokhtarian. (Received 9/24/99; accepted 1/5/00.) 40-Inducible Bcl-2 Family Member A1 Protects B Cells from Antigen Receptor-Mediated Apoptosis. Andrew Craxton, Peter I. Chuang, Geraldine Shu, John M. Harlan, and Edward A. Clark. (Received 12/13/99; accepted 1/9/00.) ro Characterization of Five Humanized OKT3 Effector Function Variant Antibodies. Danlin Xu, Maria-Luisa Alegre, Sally S. Varga, Annette L. Rothermel, Alexander M. Collins, Virginia L. Pulito, Lewis S. Hanna, Kevin P. Dolan, Paul W. H. I. Parren, Jeffrey A. Bluestone, Linda K. Jolliffe, and Robert A. Zivin. (Received 8/12/99; accepted 1/10/00.) ential Control of Neonatal Tolerance by Antigen Dose versus Extended Exposure and Adjuvant. Booki Min, Kevin L. Legge, Jacque C. Caprio, Lequn Li, Randal Gregg, and Habib Zaghouani. (Received 9/29/99; accepted 1/10/00.)